Public-Private German Seed Fund Celebrates Major Exit
The High-Tech Gründerfonds (HTGF) will sell its shares in start-up Cardior Pharmaceuticals as part of a billion-euro acquisition by industry giant Novo Nordisk.
Your company is already operating in Germany and you would now like to export worldwide?
The High-Tech Gründerfonds (HTGF) will sell its shares in start-up Cardior Pharmaceuticals as part of a billion-euro acquisition by industry giant Novo Nordisk.
The Japanese pharmaceutical giant will expand its Pfaffenhofen location in southern Germany into an international innovation center.
Germany’s healthcare sector enjoyed a successful year with a resurgent biotech sector generating a quarter of new capital. New therapies are being developed for a range of autoimmune diseases and telemedicine service are on the rise.
The injectable Mounjaro that will be mass produced by Eli Lilly and Company in Germany has been cleared for use in helping people shed pounds.
In 2023, there was a notable resurgence in the financing available to Germany's biotechnology sector.
Germany is undertaking a “digital revolution” in healthcare and now has a strategy to make life easier for pharmaceutical companies.
The 2022 Top 100 of medium-sized German companies with the best growth prospects shows a clear trend toward a trio of sectors.
The 2023 Health-i recognizes a trio of fledgling companies – CureVision, RadioReport and Semanux.
Innovative start-ups are booming in Germany's attractive life sciences sector.
Therapeutics and autonomous driving, recycling and space junk, are all part of our regular survey of some of the most interesting developments in German research and development.